Lupus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus
Condition:   Lupus Erythematosus, Systemic Interventions:   Drug: JMKX000189;   Drug: Placebo Sponsor:   Jemincare Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
Condition:   SLE Interventions:   Drug: ESK-001;   Drug: Placebo Sponsor:   Alumis Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials

the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
Condition:   Lupus Nephritis Interventions:   Diagnostic Test: lipid profile;   Diagnostic Test: fasting blood suger Sponsor:   Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials

Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
Condition:   SLE Interventions:   Drug: ESK-001;   Drug: Placebo Sponsor:   Alumis Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials

the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
Condition:   Lupus Nephritis Interventions:   Diagnostic Test: lipid profile;   Diagnostic Test: fasting blood suger Sponsor:   Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials

Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
Condition:   SLE Interventions:   Drug: ESK-001;   Drug: Placebo Sponsor:   Alumis Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials

the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
Condition:   Lupus Nephritis Interventions:   Diagnostic Test: lipid profile;   Diagnostic Test: fasting blood suger Sponsor:   Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials

Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
Condition:   SLE Interventions:   Drug: ESK-001;   Drug: Placebo Sponsor:   Alumis Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials